Analytical Data
-
Gene name
PSA
- Application
-
Alternative Names
NPEPPS; AAP-S; Metalloproteinase MP100; Cytosol alanyl aminopeptidase
-
Species
Human
-
Source
E. coli
-
Tag
N-His
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
P55786
-
Expression Region
Gly584~Gln793
-
Molecular Weight
25kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
Phosphatidylserine (PSA) is a phospholipid component of cell membranes that plays a crucial role in cellular signaling, apoptosis, and immune responses. In recent years, the research on PSA and its recombinant proteins has gained significant attention due to their potential applications in both therapeutic and diagnostic fields. Recombinant PSA proteins are engineered to enhance their functional properties, allowing for greater specificity and efficacy in various biomedical applications. Researchers are investigating their roles in cancer therapy, where PSA can be utilized as a target for immuno-oncology approaches, enabling the development of more effective cancer vaccines and targeted therapies. Additionally, PSA's ability to modulate immune responses has spurred interest in its use for autoimmune diseases and inflammatory conditions. By utilizing advanced techniques such as genetic engineering and protein expression systems, scientists can produce large quantities of purified PSA proteins, facilitating detailed studies on their structural and functional characteristics. This research not only aims to elucidate the underlying mechanisms of PSA in cellular processes but also seeks to explore novel therapeutic strategies, thus advancing our understanding of its potential as a biomarker and therapeutic target in diverse medical conditions. As the field progresses, the continued exploration of recombinant PSA proteins offers promising avenues for innovative treatment modalities and enhances our capability to tackle complex diseases.
